Liao G - Search Results

1

iRGD-decorated red shift emissive carbon nanodots for tumor targeting fluorescence imaging.

Yang Y, Wang X, Liao G, Liu X, Chen Q, Li H, Lu L, Zhao P, Yu Z. Yang Y, et al. Among authors: liao g. J Colloid Interface Sci. 2018 Jan 1;509:515-521. doi: 10.1016/j.jcis.2017.09.007. Epub 2017 Sep 6. J Colloid Interface Sci. 2018. PMID: 28923749

2

Long Circulating Polymeric Nanoparticles for Gene/Drug Delivery.

Hu J, Sheng Y, Shi J, Yu B, Yu Z, Liao G. Hu J, et al. Among authors: liao g. Curr Drug Metab. 2018;19(9):723-738. doi: 10.2174/1389200219666171207120643. Curr Drug Metab. 2018. PMID: 29219050 Review.

3

iRGD-Mediated and Enzyme-Induced Precise Targeting and Retention of Gold Nanoparticles for the Enhanced Imaging and Treatment of Breast Cancer.

Yang Y, Chen Q, Li S, Ma W, Yao G, Ren F, Cai Z, Zhao P, Liao G, Xiong J, Yu Z. Yang Y, et al. Among authors: liao g. J Biomed Nanotechnol. 2018 Aug 1;14(8):1396-1408. doi: 10.1166/jbn.2018.2592. J Biomed Nanotechnol. 2018. PMID: 29903055

4

An Overview of HDAC Inhibitors and their Synthetic Routes.

Peng X, Liao G, Sun P, Yu Z, Chen J. Peng X, et al. Among authors: liao g. Curr Top Med Chem. 2019;19(12):1005-1040. doi: 10.2174/1568026619666190227221507. Curr Top Med Chem. 2019. PMID: 30827245 Review.

5

Recent Advance in Polymer Based Microspheric Systems for Controlled Protein and Peptide Delivery.

Yang Y, Chen Q, Lin J, Cai Z, Liao G, Wang K, Bai L, Zhao P, Yu Z. Yang Y, et al. Among authors: liao g. Curr Med Chem. 2019;26(13):2285-2296. doi: 10.2174/0929867326666190409130207. Curr Med Chem. 2019. PMID: 30963961 Review.

6

Natural products as LSD1 inhibitors for cancer therapy.

Fang Y, Yang C, Yu Z, Li X, Mu Q, Liao G, Yu B. Fang Y, et al. Among authors: liao g. Acta Pharm Sin B. 2020 Jun 20;11(3):621-31. doi: 10.1016/j.apsb.2020.06.007. Online ahead of print. Acta Pharm Sin B. 2020. PMID: 32837872 Free PMC article. Review.

7

Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction as Potential Anticancer Agents.

Cheng B, Ren Y, Niu X, Wang W, Wang S, Tu Y, Liu S, Wang J, Yang D, Liao G, Chen J. Cheng B, et al. Among authors: liao g. J Med Chem. 2020 Aug 13;63(15):8338-8358. doi: 10.1021/acs.jmedchem.0c00574. Epub 2020 Jul 30. J Med Chem. 2020. PMID: 32667799

8

Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice.

Huang QJ, Liao GC, Zhuang XR, Yang ML, Yao JJ, Deng JH, Zhang YM, Wang Y, Qi XX, Pan DF, Guan Y, Huang ZY, Zhang FX, Liu ZQ, Lu LL. Huang QJ, et al. Acta Pharmacol Sin. 2022 Jul;43(7):1843-1856. doi: 10.1038/s41401-021-00775-5. Epub 2021 Nov 29. Acta Pharmacol Sin. 2022. PMID: 34845369 Free PMC article.

9

Fully synthetic Mincle-dependent self-adjuvanting cancer vaccines elicit robust humoral and T cell-dependent immune responses and protect mice from tumor development.

Luo X, Lian Q, Li W, Chen L, Zhang R, Yang D, Gao L, Qi X, Liu Z, Liao G. Luo X, et al. Among authors: liao g. Chem Sci. 2021 Dec 1;12(48):15998-16013. doi: 10.1039/d1sc05736g. eCollection 2021 Dec 15. Chem Sci. 2021. PMID: 35024123 Free PMC article.

10

The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy.

Liao G, Yang D, Ma L, Li W, Hu L, Zeng L, Wu P, Duan L, Liu Z. Liao G, et al. Eur J Med Chem. 2018 Nov 5;159:1-9. doi: 10.1016/j.ejmech.2018.09.044. Epub 2018 Sep 18. Eur J Med Chem. 2018. PMID: 30253242 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,043 results

Search Page

Filters